These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 7585610

  • 1. Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization.
    Qian J, Bostwick DG, Takahashi S, Borell TJ, Herath JF, Lieber MM, Jenkins RB.
    Cancer Res; 1995 Nov 15; 55(22):5408-14. PubMed ID: 7585610
    [Abstract] [Full Text] [Related]

  • 2. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.
    Jenkins RB, Qian J, Lieber MM, Bostwick DG.
    Cancer Res; 1997 Feb 01; 57(3):524-31. PubMed ID: 9012485
    [Abstract] [Full Text] [Related]

  • 3. Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization.
    Qian J, Jenkins RB, Bostwick DG.
    Mod Pathol; 1997 Nov 01; 10(11):1113-9. PubMed ID: 9388062
    [Abstract] [Full Text] [Related]

  • 4. Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression.
    Qian J, Hirasawa K, Bostwick DG, Bergstralh EJ, Slezak JM, Anderl KL, Borell TJ, Lieber MM, Jenkins RB.
    Mod Pathol; 2002 Jan 01; 15(1):35-44. PubMed ID: 11796839
    [Abstract] [Full Text] [Related]

  • 5. Chromosomal anomalies in stage D1 prostate adenocarcinoma primary tumors and lymph node metastases detected by fluorescence in situ hybridization.
    Gburek BM, Kollmorgen TA, Qian J, D'Souza-Gburek SM, Lieber MM, Jenkins RB.
    J Urol; 1997 Jan 01; 157(1):223-7. PubMed ID: 8976257
    [Abstract] [Full Text] [Related]

  • 6. High-grade prostate intraepithelial neoplasia shares cytogenetic alterations with invasive prostate cancer.
    Alcaraz A, Barranco MA, Corral JM, Ribal MJ, Carrió A, Mallofré C, Llopis J, Cetina A, Alvarez-Vijande R.
    Prostate; 2001 Apr 01; 47(1):29-35. PubMed ID: 11304727
    [Abstract] [Full Text] [Related]

  • 7. Potential markers of aggressiveness in prostatic intraepithelial neoplasia detected by fluorescence in situ hybridization.
    Qian J, Jenkins RB, Bostwick DG.
    Eur Urol; 1996 Apr 01; 30(2):177-84. PubMed ID: 8875198
    [Abstract] [Full Text] [Related]

  • 8. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
    Alers JC, Krijtenburg PJ, Rosenberg C, Hop WC, Verkerk AM, Schröder FH, van der Kwast TH, Bosman FT, van Dekken H.
    Lab Invest; 1997 Nov 01; 77(5):437-48. PubMed ID: 9389787
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. p53 Alteration and chromosomal instability in prostatic high-grade intraepithelial neoplasia and concurrent carcinoma: analysis by immunohistochemistry, interphase in situ hybridization, and sequencing of laser-captured microdissected specimens.
    Al-Maghrabi J, Vorobyova L, Chapman W, Jewett M, Zielenska M, Squire JA.
    Mod Pathol; 2001 Dec 01; 14(12):1252-62. PubMed ID: 11743048
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies.
    Takahashi S, Qian J, Brown JA, Alcaraz A, Bostwick DG, Lieber MM, Jenkins RB.
    Cancer Res; 1994 Jul 01; 54(13):3574-9. PubMed ID: 8012984
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evidence of multifocality of telomere erosion in high-grade prostatic intraepithelial neoplasia (HPIN) and concurrent carcinoma.
    Vukovic B, Park PC, Al-Maghrabi J, Beheshti B, Sweet J, Evans A, Trachtenberg J, Squire J.
    Oncogene; 2003 Apr 03; 22(13):1978-87. PubMed ID: 12673203
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Fluorescence in situ hybridization analysis of matched primary tumour and lymph-node metastasis of D1 (pT2-3pN1M0) prostate cancer.
    Alcaraz A, Corral JM, Ribal MJ, Mallofré C, Mengual L, Carrió A, Gil-Vernet Sedó JM, Villavicencio H.
    BJU Int; 2004 Aug 03; 94(3):407-11. PubMed ID: 15291877
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Genetic and chromosomal alterations in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization.
    Qian J, Jenkins RB, Bostwick DG.
    Eur Urol; 1999 Aug 03; 35(5-6):479-83. PubMed ID: 10325509
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.